Annexin A5 reduces infarct size and improves cardiac function after myocardial ischemia-reperfusion injury by suppression of the cardiac inflammatory response
Abstract Annexin A5 (AnxA5) is known to have anti-inflammatory and anti-apoptotic properties. Inflammation and apoptosis are key processes in post-ischemic cardiac remodeling. In this study, we investigated the effect of AnxA5 on left ventricular (LV) function and remodeling three weeks after myocar...
Guardado en:
Autores principales: | Rob C. M. de Jong, Niek J. Pluijmert, Margreet R. de Vries, Knut Pettersson, Douwe E. Atsma, J. Wouter Jukema, Paul H. A. Quax |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/50bd8d889bfd42e0baca7bd420a4b082 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Increased cardiac distribution of mono-PEGylated Radix Ophiopogonis polysaccharide in both myocardial infarction and ischemia/reperfusion rats
por: Yao CX, et al.
Publicado: (2015) -
Influence of Intrinsic Aerobic Exercise Capacity and Sex on Cardiac Injury Following Acute Myocardial Ischemia and Reperfusion
por: Musaad B. Alsahly, et al.
Publicado: (2021) -
Cardiac Tissue Engineering for the Treatment of Myocardial Infarction
por: Dongmin Yu, et al.
Publicado: (2021) -
The Antioxidant Transcription Factor Nrf2 in Cardiac Ischemia–Reperfusion Injury
por: Ana Mata, et al.
Publicado: (2021) -
Eosinophils improve cardiac function after myocardial infarction
por: Jing Liu, et al.
Publicado: (2020)